Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Comprehensive genomic profiling of Finnish lung adenocarcinoma cohort reveals high clinical actionability and SMARCA4 altered tumors with variable histology and poor prognosis.
Neoplasia. 2022 Oct;32:100832. doi: 10.1016/j.neo.2022.100832. Epub 2022 Aug 11.
Neoplasia. 2022.
PMID: 35964518
Free PMC article.
High tumor mutation burden predicts favorable outcome among patients with aggressive histological subtypes of lung adenocarcinoma: A population-based single-institution study.
Talvitie EM, Vilhonen H, Kurki S, Karlsson A, Orte K, Almangush A, Mohamed H, Liljeroos L, Singh Y, Leivo I, Laitinen T, Kallajoki M, Taimen P.
Talvitie EM, et al. Among authors: vilhonen h.
Neoplasia. 2020 Sep;22(9):333-342. doi: 10.1016/j.neo.2020.05.004. Epub 2020 Jun 22.
Neoplasia. 2020.
PMID: 32585428
Free PMC article.
Clinical Trial.
Item in Clipboard
Retrospective Evaluation of Lung Adenocarcinoma Patients Progressing on 1st Line Chemotherapy.
Vilhonen H, Kurki S, Laitinen T, Hirsjärvi S.
Vilhonen H, et al.
Medicina (Kaunas). 2019 Nov 16;55(11):743. doi: 10.3390/medicina55110743.
Medicina (Kaunas). 2019.
PMID: 31744064
Free PMC article.
Item in Clipboard
Cite
Cite